![]() Schwartz and colleagues have discovered that SARS-CoV-2 has broad impacts and affects organs beyond the lung. His research has recently expanded to investigating how SARS-CoV-2 impacts human cells and their phenotype and function. He builds laboratory models of liver diseases using stem cells and tissue-engineering techniques to reveal the underlying processes of nonalcoholic fatty liver disease, metabolic liver diseases and viral infections that affect the liver, including hepatitis, Zika and herpes simplex. Robert Schwartz is an associate professor of medicine in the Division of Gastroenterology and Hepatology and a faculty member in the Weill Cornell Graduate School of Medical Sciences’ Physiology, Biophysics and Systems Biology program. “As a physician-scientist, the most important thing for me is that my research discoveries may translate into clinical treatments that help patients.”ĭr. Longman, who is also a member of the Jill Roberts Institute for Research in Inflammatory Bowel Disease. “It’s very meaningful to be elected as a member of the ASCI, knowing my peers recognize my work has contributed toward moving the needle forward,” said Dr. Longman’s research is funded by several organizations, including the National Institutes of Health and the Crohn’s and Colitis Foundation. Supported by the National Institute of Diabetes and Digestive and Kidney Diseases, the trial is based on his earlier work that identified specific microbes associated with clinical responses to FMT. Longman is currently leading a clinical trial evaluating whether dietary fiber supplementation may improve the efficacy of fecal microbiota transplantation (FMT) in patients with moderate ulcerative colitis. His work has identified specific strains of bacteria that are involved and how they relay signals to the immune system to activate inflammation in patients with Crohn’s disease and ulcerative colitis, the most common forms of IBD.ĭr. His research focuses on interactions between gut microbes and the immune system in inflammatory bowel disease (IBD). Randy Longman is an associate professor of medicine in the Division of Gastroenterology and Hepatology at Weill Cornell Medicine and director of the Jill Roberts Center for Inflammatory Bowel Disease at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |